Creative Biolabs Introduces All-inclusive Exosome-related Services

As a world-leading service provider in the exosome field, Creative Biolabs has spared no efforts to update its exosome-related services, aiming to unlock the full potential of exosome as novel therapeutics.

New York, United States - January 14, 2020 /MarketersMedia/ —

Exosomes are small vesicles (30-150nm in diameter) containing complex RNA and proteins, mainly derived from multivesicular bodies formed by intracellular lysosomal microsomes. They have received extensive attention in recent years due to its function of mediating cell-to-cell communication and regulating the characteristics of target cells.

2019 witnessed rapid development of research on exosome, which is proved to play an important role in immunosurveillance and tumor pathogenesis. According to a new report by Grand View Research, Inc., the global exosomes market size is expected to reach $ 2.28 billion by 2030, with a CAGR of nearly 18.0% during the forecast period, 2019-2024.

Empowered by leading technology and years of experience in biomedical science, Creative Biolabs is confident to assist customers to exploit the exosomes by providing customized, standardized and reliable exosome products and services covering sampling, analysis, manufacturing of exosome as well as exosome-based therapeutics.

Isolation and purification are two key parts of exosome sampling. Creative Biolabs is skilled in separating exosomes derived from a wide range of cells, covering B cells, tumor cells, dendritic cells and almost all kinds of biofluid. Validated protocols have also been developed to purify exosomes with decreased co-purification of non-exosomal proteins, such as ultracentrifugation and microfiltration, immunoaffinity capture and size exclusion chromatography.

Exosome analysis mainly includes characterization, quantification, profiling as well as exosome proteomics and lipidomics & metabolomics. Take exosome profiling as an example, Creative Biolabs provides different exosomal profiling platforms for the isolation, purification, quantification, and analysis of required exosomes, mainly including isolation and profiling of exosomal RNA, exosomal cfDNA, exosomal protein and Exosome-NGS (RNA next generation sequencing).

“Although the detection and molecular analysis of exosomes is very challenging, we have equipped ourselves with advanced equipment and platforms to achieve multifarious exosome profiling according to its specific contents.” Said a senior scientist in Creative Biolabs.

Exosome manufacturing consists of engineering and manufacturing. Supported by exosome engineering platforms, scientists in Creative Biolabs can extensively refresh mechanisms of exosome functions with several advanced systems for exosome labeling, targeting and load cargo into exosomes. Downstream processing is also available for customers to obtain functional or drug-loaded exosomes.

As for exosome-based applications, exosome antibodies have been widely used as exosome research tools and for clinical applications such as disease prognosis and diagnosis. To help promote the exosomal studies and their clinical use, Creative Biolabs provides high-quality antibody development services using different technologies, including phage display antibody screening and B cell sorting, which can help the discovery of antibodies that recognize exosome-associated antigens with sufficient sensitivity and specificity.

In the following decade, exosomes will attract increasing attention in their clinical applications for prognosis, diagnosis, drug delivery, and vaccine development. With an unrelenting drive in the biotechnology research area, Creative Biolabs, which will keep advancing high-quality, end-to-end services to help global customers accelerate their exosome research, hopes to do contributions to exosome application for diagnostic and therapeutic purposes. Further information can be found on:

About Creative Biolabs
Creative Biolabs is a US-based company with a history more than 15 years focusing on exosomal services and products. As a first-class biotech manufacturer, Creative Biolabs, offering high-quality and cost-effective exosome-related solutions to clients worldwide, has accumulated extensive experience in the field with hundreds of successful cases.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs

Source URL:

Source: MarketersMedia

Release ID: 88942666

Latest News

Putin engineers shakeup that could keep him in power longer

Jul 11, 2020

MOSCOW — President Vladimir Putin engineered a surprise shakeup of Russia's leadership Wednesday, proposing changes to the constitution that could keep him in power well past the end of his term in 2024. Prime Minister Dmitry Medvedev resigned his post after Putin announced the proposed constitutional amendments. Putin kept his longtime ally in the Kremlin's leadership structure, appointing him to the newly created post of deputy head of the presidential Security Council. The shakeup sent shock waves through Russia's political elites who were left pondering what Putin's intentions were and speculating about future Cabinet appointments. Putin’s proposed constitutional reforms, announced...

Sultan Qaboos bin Said, who modernized Oman, dies at 79

Jul 11, 2020

DUBAI, United Arab Emirates — Oman’s Sultan Qaboos bin Said, the Mideast's longest-ruling monarch who seized power in a 1970 palace coup and pulled his Arabian sultanate into modernity while carefully balancing diplomatic ties between adversaries Iran and the U.S., has died. He was 79. The British-educated, reclusive sultan reformed a nation that was home to only three schools and harsh laws banning electricity, radios, eyeglasses and even umbrellas when he took the throne. Under his reign, Oman became known as a welcoming tourist destination and a key Mideast interlocutor, helping the U.S. free captives in Iran and Yemen and...

On streets of Tehran, relief for now at no wider conflict

Jul 11, 2020

TEHRAN, Iran — Iranian newspapers proclaimed the country's attack on U.S. forces in Iraq to be "a dark night for Americans," and Washington's "first admission of failure in history." On the bustling streets of Tehran, however, there was relief Thursday that neither side appeared primed for war. “War is not something like the ‘Call of Duty’ game," said Dara Shojaei, a 23-year-old architecture student. “It's not a game you can play to win. There's no winner.” But with the relief came some mixed feelings about how far Iran should go to avenge the killing of Revolutionary Guard Gen. Qassem Soleiman,...

Stocks rise as China confirms trade deal signing next week

Jul 11, 2020

NEW YORK — U.S stocks climbed in morning trading on Thursday as investors cheered confirmation from China that its top trade official will head to Washington next week to sign a preliminary trade deal. The “Phase 1” accord is the opening step on a possible path toward a broader agreement between the nations. President Donald Trump has said he will travel to Beijing after the initial signing to start the second stage of talks. Every major index is on track for a record as Wall Street distances itself from a bout of anxiety over the last week because of tensions...

Soleimani, a general who became Iran icon by targeting US

Jul 11, 2020

TEHRAN, Iran — For Iranians whose icons since the Islamic Revolution have been stern-faced clergy, Maj. Gen. Qassem Soleimani widely represented a figure of national resilience in the face of four decades of U.S. pressure. For the U.S. and Israel, he was a shadowy figure in command of Iran's proxy forces, responsible for fighters in Syria backing President Bashar Assad and for the deaths of American troops in Iraq. Solemani survived the horror of Iran’s long war in the 1980s with Iraq to take control of the Revolutionary Guard’s elite Quds Force, responsible for the Islamic Republic’s foreign campaigns. Relatively...


Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: